GBM AGILE: A global, phase 2/3 adaptive platform trial to evaluate multiple regimens in newly diagnosed and recurrent glioblastoma Meeting Abstract
| Authors: | Buxton, M.; Alexander, B.; Berry, D.; Cavenee, W.; Colman, H.; de Groot, J.; Ellingson, B.; Gordon, G.; Khasraw, M.; Lassman, A.; Lee, W.; Lim, M.; Mellinghoff, I.; Perry, J.; Sulman, E.; Tanner, K.; Weller, M.; Wen, P.; Yung, W. K. A.; Cloughesy, T.; and GBM AGILE Investigators |
| Abstract Title: | GBM AGILE: A global, phase 2/3 adaptive platform trial to evaluate multiple regimens in newly diagnosed and recurrent glioblastoma |
| Meeting Title: | 25th Virtual Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology |
| Journal Title: | Neuro-Oncology |
| Volume: | 22 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2020 Nov 19-21 |
| Meeting Location: | Virtual |
| ISSN: | 1522-8517 |
| Publisher: | Oxford University Press |
| Date Published: | 2020-11-01 |
| Start Page: | ii195 |
| End Page: | ii196 |
| Language: | English |
| ACCESSION: | WOS:000590061300817 |
| PROVIDER: | wos |
| DOI: | 10.1093/neuonc/noaa215.816 |
| Notes: | Meeting Abstract: RTID-11 -- Source: Wos |
